Intellectual Property
Trade Secret Misappropriation
Tortious Interference With a Prospective Economic Advantage
Teva Pharmaceuticals USA Inc., Teva Canada Innovation G.P.-S.E.N.C. v. Health IQ LLC, Amgen Inc., Amgen USA Inc., Amgen Canada Inc., Amgen International Inc., Amgen (Europe) GMBH
Published: May 18, 2013 | Result Date: Apr. 29, 2013 | Filing Date: Jan. 1, 1900 |Case number: 8:13-cv-00308-CJC-RNB Bench Decision – Dismissal
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In